These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 364967

  • 1. Aprindine.
    Danilo P.
    Am Heart J; 1979 Jan; 97(1):119-24. PubMed ID: 364967
    [Abstract] [Full Text] [Related]

  • 2. Aprindine: a review.
    Stoel I, Hagemeijer F.
    Eur Heart J; 1980 Apr; 1(2):147-56. PubMed ID: 7026249
    [No Abstract] [Full Text] [Related]

  • 3. Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome.
    Reid PR, Greene HL, Varghese PJ.
    Br Heart J; 1977 Dec; 39(12):1353-60. PubMed ID: 603737
    [Abstract] [Full Text] [Related]

  • 4. Prolongation of cardiac conduction times by intravenous aprindine in man.
    Greene HL, Reid PR, Schaeffer AH.
    Am J Cardiol; 1978 Dec; 42(6):1002-6. PubMed ID: 727127
    [Abstract] [Full Text] [Related]

  • 5. Aprindine therapy for refractory ventricular tachycardia.
    Khan AH, Carleton RA, Chown M.
    Arch Intern Med; 1983 Feb; 143(2):229-32. PubMed ID: 6824389
    [Abstract] [Full Text] [Related]

  • 6. [Electrophysiological study of aprindine].
    Ponsonnaille J, Marcheix JC, Gras H.
    Ann Cardiol Angeiol (Paris); 1978 Feb; 27(3):247-50. PubMed ID: 666259
    [No Abstract] [Full Text] [Related]

  • 7. Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome.
    Zipes DP, Gaum WE, Foster PR, Rosen KM, Wu D, Amat-Y-Leon F, Noble RJ.
    Am J Cardiol; 1977 Oct; 40(4):586-96. PubMed ID: 910722
    [No Abstract] [Full Text] [Related]

  • 8. Long-term oral antiarrhythmic therapy with aprindine: effects on cardiac function and adverse effects.
    Tsutsui H, Araki H, Nagata Y, Nakamura M.
    Clin Ther; 1984 Oct; 6(6):770-7. PubMed ID: 6509460
    [Abstract] [Full Text] [Related]

  • 9. Studies with aprindine.
    Zipes DP, Elharrar V, Gilmour RF, Heger JJ, Prystowsky EN.
    Am Heart J; 1980 Dec; 100(6 Pt 2):1055-62. PubMed ID: 6255785
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of the electrophysiological effects of aprindine in man, with particular regard to the ventricular preexcitation syndrome (author's transl)].
    Vergara G, Disertori M, Molinis G, Inama G, Antonini L, Del Favero A, Stefenelli C, Furlanello F.
    G Ital Cardiol; 1979 Dec; 9(6):597-606. PubMed ID: 488596
    [No Abstract] [Full Text] [Related]

  • 11. Suppression of the repetitive ventricular response: an index of long-term antiarrhythmic effectiveness of aprindine for ventricular tachycardia in man.
    Schaeffer AH, Greene HL, Reid PR.
    Am J Cardiol; 1978 Dec; 42(6):1007-12. PubMed ID: 727128
    [Abstract] [Full Text] [Related]

  • 12. Aprindine for treatment of ventricular arrhythmias in the dog.
    Muir WW, Bonagura JD.
    Am J Vet Res; 1982 Oct; 43(10):1815-9. PubMed ID: 7149383
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of a new drug (Aprindine) on ventricular and superventricular arrhythmia].
    Villalobos Galán E, Martin Santos F, Fernández Corral E, de Elio Membrado FJ.
    Rev Clin Esp; 1975 Sep 15; 138(5):461-8. PubMed ID: 1178995
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical efficacy and plasma levels of oral aprindine, a new antiarrhythmic drug].
    Kikuchi H, Honda T, Kugimiya H, Matuda H, Matunaga T, Takemiya S, Hayasaki K.
    Kokyu To Junkan; 1985 Mar 15; 33(3):433-40. PubMed ID: 4012073
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of aprindine on ventricular arrhthmias].
    Domínguez JF, Martín Sánchez JC, Ciscar A, Hidalgo M, Petit Guinovart M, Ballesta Barcons F.
    Rev Esp Cardiol; 1975 Mar 15; 38(2):145-52. PubMed ID: 49071
    [No Abstract] [Full Text] [Related]

  • 16. Agranulocytosis associated with aprindine therapy.
    Bodenheimer HC, Samarel AM.
    Arch Intern Med; 1979 Oct 15; 139(10):1181-2. PubMed ID: 485754
    [Abstract] [Full Text] [Related]

  • 17. Aprindine hepatitis.
    Herlong HF, Reid PR, Boitnott JK, Maddrey WC.
    Ann Intern Med; 1978 Sep 15; 89(3):359-61. PubMed ID: 686550
    [Abstract] [Full Text] [Related]

  • 18. [Aprindine, an anti-arrhythmia agent for arrhythmia associated with myocardial infarct].
    Ikeda T, Kubota K, Higashino A, Hattori N.
    Nihon Rinsho; 1983 Dec 15; 41(12):2760-5. PubMed ID: 6674561
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of recurrent ventricular tachycardia and fibrillation with aprindine.
    Fasola AF, Noble RJ, Zipes DP.
    Am J Cardiol; 1977 May 26; 39(6):903-9. PubMed ID: 67800
    [Abstract] [Full Text] [Related]

  • 20. [Fatal course of agranulocytosis during antiarryhthmic aprindine therapy].
    Hausamen TU, Weber FW.
    Dtsch Med Wochenschr; 1977 Oct 21; 102(42):1523-4. PubMed ID: 913289
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.